HC
Henan Cancer Hospital at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Henan Cancer Hospital brings 20 presentations to ASH 2026 in New Orleans. Its research centres on multiple myeloma, acute myeloid leukemia and diffuse large B-cell lymphoma treatment. It covers first-line polatuzumab vedotin in double-expressor lymphoma and alternating maintenance with venetoclax and azacitidine.
| Organization | ASH 2026 Attendance |
|---|---|
HC Henan Cancer Hospital Zhengzhou, China | |
Cancer hospital in Zhengzhou, China. | Oral Sat Dec 12 4:00pm–5:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Poster Sun Dec 13 6:00pm–8:00pm Oral Mon Dec 14 2:45pm–4:15pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm Poster Mon Dec 14 6:00pm–8:00pm |
Find decision makers at Henan Cancer Hospital
Tell us what you sell and we’ll find the people at Henan Cancer Hospital most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction